Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for obsessive-compulsive disorder
IRCT201204271556N41Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron in obsessive compulsive disorder (OCD), sponsored by Tehran University of Medical Sciences. Started Apr 2012; status: completed.
02
Drugs
ondansetron
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT201204271556N41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201204271556N41.